undamentalytics Newsletter
Sign in

Ironwood Pharmaceuticals Inc income statement

In fiscal 2025, Ironwood Pharmaceuticals Inc reported revenue of $296m, down 15.7% on the year before, operating income of $98.5m (a 33.3% margin) and net income of $24.0m, or $0.15 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2009Dec 20092010Dec 20102011Dec 20112012Dec 20122013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue3444661502376150274298347428390414411443351296389
Cost of revenue———175021933243——————
Gross profit———1491671150272279314405386——————
Research and development767786113102102109139881011158870441161119589
Selling, general and administrative—2746931231181251732312201721401111161581448265
General and administrative19—————————————————
Operating income−61−61−66−73−252−169−102−52−15−151120143232250−9459399234
Interest expense0000212131393638372931822333333
Income before tax−60−59−65−73−273————−19459109201252−9486570207
Income tax−0−30——0000003−3287783644678
Net income−71−53−65−73−273−190−143−82−117−28222106528175−1,002124130
Diluted EPS−$10.00−$0.59−$0.65−$0.68−$2.35−$1.39−$1.00−$0.56−$0.78−$1.85$0.14$0.66$3.21$0.96−$6.45$0.01$0.15$0.80
Diluted shares (average)7m90m100m106m116m137m142m145m149m153m156m161m164m186m155m160m163m162m
EBITDA−56−55−56−61−240−157−90−42−9−147126145234252−94494100235

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: INVA vs IRWDIRWD vs XERSEOLS vs IRWD

More: Pharmaceuticals stocks compared, Health Care sector, rankings of US companies

Figures from Ironwood Pharmaceuticals Inc's SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Ironwood Pharmaceuticals Inc.